skip nav
  Home | About CDC | Press Room | A-Z Index | Contact Us
spacer
spacer Image map: please use the alternative links provided with the map. CDC Centers for Disease Control and Prevention Home Page spacer
CDC en Español
spacer
 
spacer
spacer
spacer
spacer
spacer
Global HIV/AIDS
spacer
spacer
 Global HIV/AIDS Topics
space
arrow Home
space
arrow Global HIV/AIDS at CDC
space
arrow Global Programs
space
arrow Strategies
space
arrow Resources
space
arrow Employment
space
space
  View By Topic
space
arrow NCHHSTP Home
space
arrow HIV/AIDS Prevention
space
arrow Global HIV/AIDS
space
arrow TB Elimination
space
arrow STD Prevention
space
arrow Viral Hepatitis
space
arrow CDC International Lab Resources
space
space
horizontal dividing line
Contact Us
CDC-INFO
800-CDC-INFO
800-232-4636
TTY: 888-232-6348
24 Hours/Day
E-mail: cdcinfo@cdc.gov

CDC NPIN (National Prevention Information Network)
800-CDC-NPIN
800-458-5231
TTY: 800-243-7012
M-F 9am-6pm (ET)
E-mail: info@cdcnpin.org
divider
spacer spacer
spacer
Skip Nav spacer
spacer
About Our Work: Surveillance (Last Updated: January 2005)
spacer
spacer
one page description
Printer-Friendly Version

Closely tracking trends in HIV/AIDS risk behaviors, prevalence, incidence, and deaths helps inform policymakers about the realities and priorities in relation to the HIV epidemic. Surveillance systems can be used to assess the extent, trends, and impact of the HIV epidemic, and also the success of HIV prevention and care efforts.

The data gathered by surveillance systems are useful for setting or modifying priorities for prevention, care and treatment. However, faced with competing priorities, many developing countries have not been able to sustain a reliable HIV/AIDS surveillance system, and are unable to provide the critical data and analysis needed for decision- making.

The U.S. Government (USG) through the Global AIDS Program (GAP) assists host countries in enhancing or developing HIV surveillance systems, as well as using the results of surveillance surveys. GAP negotiates specific technical assistance activities with each host country, taking into consideration capacity as well as existing partnerships and activities.

In Angola, Guyana, Kenya, Nigeria, Botswana, Ethiopia, Zambia, Tanzania, Côte d'Ivoire, Democratic Republic of Congo and Zimbabwe with U.S. Government (USG) funding, GAP... assists with training, and financial support for prenatal HIV sentinel surveillance.

In Cambodia and Vietnam, with USG funding, GAP... assists with training and financial support for HIV sentinel surveillance in high risk groups such as police, injection drug users, commercial sex workers.

In Kenya, Uganda, Haiti, Cambodia, Vietnam, Côte d'Ivoire and Zimbabwe... assists with protocol development, HIV testing, implementation and analysis of a population-based survey with HIV testing.

dotline

"Sur-veil-lance: to keep close watch over"

What HIV/AIDS trends does CDC track?

  • Serologic surveillance: the level of HIV infection in the population and trends in HIV infection levels.
  • Behavioral surveillance: the risks for HIV and analysis of how those behaviors impact HIV levels and changes in those levels.
  • Morbidity surveillance: the proportion of persons with HIV infection who are ill and trends in this proportion over time.
  • Mortality surveillance: the trends in deaths due to HIV over time.

dotline

BED Assay Recommendations

The President's Emergency Plan for AIDS Relief Surveillance and Survey and Laboratory Working Groups have developed interim recommendations for BED assay for HIV-1 incidence estimation and surveillance in U.S. government supported activities.

The interim recommendations state that the BED assay can be applied to sentinel or population-based surveys and HIV-1 prevention intervention designs to estimate HIV-1 incidence if appropriate adjustments are made and appropriate experts are consulted. (The contact information of these experts is contained within these interim recommendations). Furthermore, the BED assay can be used to estimate HIV-1 incidence in case-based HIV-1 surveillance systems only under certain circumstances.

For more information regarding the use of BED assay for HIV-1 incidence estimation and surveillance, contact Dr. Bharat Parekh (BParekh@cdc.gov) or Dr. Andrea Kim (AAKim@cdc.gov).

« Go back

spacerLast Modified: 10/28/2008
 Last Reviewed: March 27, 2007
 Content Source:
 Global AIDS Program (GAP)
 National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention
spacer
spacer
spacer
spacer
Home | Policies and Regulations | Disclaimer | e-Government | FOIA | Contact Us
spacer
spacer
spacer Safer, Healthier People
spacer
Centers for Disease Control and Prevention, 1600 Clifton Rd, Atlanta, GA 30333, U.S.A
Tel: (404) 639-3311 / Public Inquiries: (404) 639-3534 / (800) 311-3435
spacer FirstGovDHHS Department of Health
and Human Services